Persistence Market Research Company
Customize Now Get FREE Sample

Molecular Diagnostics in Infectious Disease Testing Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Molecular Diagnostics in Infectious Disease Testing Market by Type of LNP (Instruments and Analyzers, Assays and Reagents, Services and Software), Therapeutic Area (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, Next-Generation Sequencing (NGS), Hybridization, Others), Application (Hepatitis B, Hepatitis C, AIDS, Tuberculosis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Hospital-Acquired Infections, Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV) Infection, Others), End User (Hospitals, Private Labs, Clinics, Academic Institutes, Laboratories, Others), and Regional Analysis from 2026 to 2033.

ID: PMRREP4427| 201 Pages | 20 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Molecular Diagnostics in Infectious Disease Testing Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
    3. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Product, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
        1. Instruments and Analyzers
        2. Assays and Reagents
        3. Services and Software
      4. Market Attractiveness Analysis: Product
    4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook: Technique
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Technique, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
        1. Polymerase Chain Reaction (PCR)
        2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        3. Microarrays
        4. Next-Generation Sequencing (NGS)
        5. Hybridization
        6. Others
      4. Market Attractiveness Analysis: Technique
    5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
        1. Hepatitis B
        2. Hepatitis C
        3. AIDS
        4. Tuberculosis
        5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
        6. Hospital-Acquired Infections
        7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
        8. Human Papillomavirus (HPV) Infection
        9. Others
      4. Market Attractiveness Analysis: Application
    6. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 – 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
        1. Hospitals
        2. Private Labs
        3. Clinics
        4. Academic Institutes
        5. Laboratories
        6. Others
      4. Market Attractiveness Analysis: End User
  5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Technique
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
      1. Instruments and Analyzers
      2. Assays and Reagents
      3. Services and Software
    5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Microarrays
      4. Next-Generation Sequencing (NGS)
      5. Hybridization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
      1. Hepatitis B
      2. Hepatitis C
      3. AIDS
      4. Tuberculosis
      5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      6. Hospital-Acquired Infections
      7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
      8. Human Papillomavirus (HPV) Infection
      9. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Private Labs
      3. Clinics
      4. Academic Institutes
      5. Laboratories
      6. Others
    8. Market Attractiveness Analysis
  7. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Technique
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
      1. Instruments and Analyzers
      2. Assays and Reagents
      3. Services and Software
    5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Microarrays
      4. Next-Generation Sequencing (NGS)
      5. Hybridization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
      1. Hepatitis B
      2. Hepatitis C
      3. AIDS
      4. Tuberculosis
      5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      6. Hospital-Acquired Infections
      7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
      8. Human Papillomavirus (HPV) Infection
      9. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Private Labs
      3. Clinics
      4. Academic Institutes
      5. Laboratories
      6. Others
    8. Market Attractiveness Analysis
  8. East Asia Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Technique
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
      1. Instruments and Analyzers
      2. Assays and Reagents
      3. Services and Software
    5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Microarrays
      4. Next-Generation Sequencing (NGS)
      5. Hybridization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
      1. Hepatitis B
      2. Hepatitis C
      3. AIDS
      4. Tuberculosis
      5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      6. Hospital-Acquired Infections
      7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
      8. Human Papillomavirus (HPV) Infection
      9. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Private Labs
      3. Clinics
      4. Academic Institutes
      5. Laboratories
      6. Others
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Technique
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
      1. Instruments and Analyzers
      2. Assays and Reagents
      3. Services and Software
    5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Microarrays
      4. Next-Generation Sequencing (NGS)
      5. Hybridization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
      1. Hepatitis B
      2. Hepatitis C
      3. AIDS
      4. Tuberculosis
      5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      6. Hospital-Acquired Infections
      7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
      8. Human Papillomavirus (HPV) Infection
      9. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Private Labs
      3. Clinics
      4. Academic Institutes
      5. Laboratories
      6. Others
    8. Market Attractiveness Analysis
  10. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Technique
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
      1. Instruments and Analyzers
      2. Assays and Reagents
      3. Services and Software
    5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Microarrays
      4. Next-Generation Sequencing (NGS)
      5. Hybridization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
      1. Hepatitis B
      2. Hepatitis C
      3. AIDS
      4. Tuberculosis
      5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      6. Hospital-Acquired Infections
      7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
      8. Human Papillomavirus (HPV) Infection
      9. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Private Labs
      3. Clinics
      4. Academic Institutes
      5. Laboratories
      6. Others
    8. Market Attractiveness Analysis
  11. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Technique
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026 – 2033
      1. Instruments and Analyzers
      2. Assays and Reagents
      3. Services and Software
    5. Market Size (US$ Bn) Analysis and Forecast, By Technique, 2026 – 2033
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. Microarrays
      4. Next-Generation Sequencing (NGS)
      5. Hybridization
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 – 2033
      1. Hepatitis B
      2. Hepatitis C
      3. AIDS
      4. Tuberculosis
      5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      6. Hospital-Acquired Infections
      7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
      8. Human Papillomavirus (HPV) Infection
      9. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 – 2033
      1. Hospitals
      2. Private Labs
      3. Clinics
      4. Academic Institutes
      5. Laboratories
      6. Others
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Abbott Laboratories
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Becton Dickinson and Company
      3. bioMérieux
      4. Thermo Fisher Scientific Inc.
      5. F. Hoffmann-La Roche Ltd
      6. Siemens AG
      7. Veridex, LLC
      8. Luminex Corp.
      9. GenMark Diagnostics, Inc.
      10. Qiagen N.V.
      11. Genomix Biotech
      12. bioTheranostics
      13. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate